These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31623826)

  • 1. Development of a model of ischemic heart disease using cardiomyocytes differentiated from human induced pluripotent stem cells.
    Wei H; Wang C; Guo R; Takahashi K; Naruse K
    Biochem Biophys Res Commun; 2019 Dec; 520(3):600-605. PubMed ID: 31623826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes.
    Liu Y; Liang Y; Wang M; Wang C; Wei H; Naruse K; Takahashi K
    J Vis Exp; 2020 May; (159):. PubMed ID: 32449739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laminin-221 Enhances Therapeutic Effects of Human-Induced Pluripotent Stem Cell-Derived 3-Dimensional Engineered Cardiac Tissue Transplantation in a Rat Ischemic Cardiomyopathy Model.
    Samura T; Miyagawa S; Kawamura T; Fukushima S; Yokoyama JY; Takeda M; Harada A; Ohashi F; Sato-Nishiuchi R; Toyofuku T; Toda K; Sekiguchi K; Sawa Y
    J Am Heart Assoc; 2020 Aug; 9(16):e015841. PubMed ID: 32783519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Glucose Attenuates Anesthetic Cardioprotection in Stem-Cell-Derived Cardiomyocytes: The Role of Reactive Oxygen Species and Mitochondrial Fission.
    Canfield SG; Zaja I; Godshaw B; Twaroski D; Bai X; Bosnjak ZJ
    Anesth Analg; 2016 May; 122(5):1269-79. PubMed ID: 26991754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes.
    Davis J; Chouman A; Creech J; Monteiro da Rocha A; Ponce-Balbuena D; Jimenez Vazquez EN; Nichols R; Lozhkin A; Madamanchi NR; Campbell KF; Herron TJ
    JCI Insight; 2021 May; 6(10):. PubMed ID: 33878037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Therapeutic Effects of Human iPS Cell Derived-Cardiomyocyte by Combined Cell-Sheets with Omental Flap Technique in Porcine Ischemic Cardiomyopathy Model.
    Kawamura M; Miyagawa S; Fukushima S; Saito A; Miki K; Funakoshi S; Yoshida Y; Yamanaka S; Shimizu T; Okano T; Daimon T; Toda K; Sawa Y
    Sci Rep; 2017 Aug; 7(1):8824. PubMed ID: 28821761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of
    Shah D; Virtanen L; Prajapati C; Kiamehr M; Gullmets J; West G; Kreutzer J; Pekkanen-Mattila M; Heliö T; Kallio P; Taimen P; Aalto-Setälä K
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac safety assessment with motion field imaging analysis of human iPS cell-derived cardiomyocytes is improved by an integrated evaluation with cardiac ion channel profiling.
    Isobe T; Honda M; Komatsu R; Tabo M
    J Toxicol Sci; 2019; 44(12):859-870. PubMed ID: 31813905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Kopljar I; Gallacher DJ; De Bondt A; Cougnaud L; Vlaminckx E; Van den Wyngaert I; Lu HR
    Stem Cells Transl Med; 2016 May; 5(5):602-12. PubMed ID: 27034410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
    Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
    Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.
    Kawamura M; Miyagawa S; Miki K; Saito A; Fukushima S; Higuchi T; Kawamura T; Kuratani T; Daimon T; Shimizu T; Okano T; Sawa Y
    Circulation; 2012 Sep; 126(11 Suppl 1):S29-37. PubMed ID: 22965990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model.
    Sugiura T; Hibino N; Breuer CK; Shinoka T
    J Cardiothorac Surg; 2016 Dec; 11(1):163. PubMed ID: 27906085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation.
    Brodarac A; Šarić T; Oberwallner B; Mahmoodzadeh S; Neef K; Albrecht J; Burkert K; Oliverio M; Nguemo F; Choi YH; Neiss WF; Morano I; Hescheler J; Stamm C
    Stem Cell Res Ther; 2015 Apr; 6(1):83. PubMed ID: 25900017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent Stem Cell-Derived Cardiomyocyte Transplantation for Heart Disease Treatment.
    Kadota S; Shiba Y
    Curr Cardiol Rep; 2019 Jun; 21(8):73. PubMed ID: 31228011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic Maturation Increases Susceptibility to Hypoxia-induced Damage in Human iPSC-derived Cardiomyocytes.
    Peters MC; Maas RGC; van Adrichem I; Doevendans PAM; Mercola M; Šarić T; Buikema JW; van Mil A; Chamuleau SAJ; Sluijter JPG; Hnatiuk AP; Neef K
    Stem Cells Transl Med; 2022 Oct; 11(10):1040-1051. PubMed ID: 36018047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of human induced pluripotent stem-cell derived cardiomyocytes with human mesenchymal stem cells following acute myocardial infarction.
    Citro L; Naidu S; Hassan F; Kuppusamy ML; Kuppusamy P; Angelos MG; Khan M
    PLoS One; 2014; 9(12):e116281. PubMed ID: 25551230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart.
    Kawamura M; Miyagawa S; Fukushima S; Saito A; Miki K; Ito E; Sougawa N; Kawamura T; Daimon T; Shimizu T; Okano T; Toda K; Sawa Y
    Circulation; 2013 Sep; 128(11 Suppl 1):S87-94. PubMed ID: 24030425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures.
    Ting S; Chen A; Reuveny S; Oh S
    Stem Cell Res; 2014 Sep; 13(2):202-13. PubMed ID: 25043964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent immunomodulation and angiogenic effects of mesenchymal stem cells versus cardiomyocytes derived from pluripotent stem cells for treatment of heart failure.
    Liao S; Zhang Y; Ting S; Zhen Z; Luo F; Zhu Z; Jiang Y; Sun S; Lai WH; Lian Q; Tse HF
    Stem Cell Res Ther; 2019 Mar; 10(1):78. PubMed ID: 30845990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.